Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $37.00 by Analysts at Mizuho

Acadia Healthcare (NASDAQ:ACHC) had its target price cut by Mizuho from $48.00 to $37.00 in a report issued on Tuesday morning,Benzinga reports. They currently have a neutral rating on the stock.

A number of other research analysts have also weighed in on ACHC. Royal Bank of Canada decreased their target price on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. TD Cowen dropped their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Bank of America decreased their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. Finally, StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Hold” and a consensus target price of $52.19.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $30.12 on Tuesday. Acadia Healthcare has a fifty-two week low of $27.61 and a fifty-two week high of $82.41. The stock has a market capitalization of $2.80 billion, a price-to-earnings ratio of 9.88, a PEG ratio of 1.46 and a beta of 1.38. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The business has a 50-day moving average of $37.41 and a 200-day moving average of $45.60.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in ACHC. Charles Schwab Investment Management Inc. grew its position in Acadia Healthcare by 2.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,127,061 shares of the company’s stock worth $71,467,000 after buying an additional 29,936 shares in the last quarter. Cerity Partners LLC raised its stake in Acadia Healthcare by 43.7% in the third quarter. Cerity Partners LLC now owns 32,922 shares of the company’s stock valued at $2,088,000 after purchasing an additional 10,019 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in Acadia Healthcare during the third quarter worth about $458,000. Bank of Montreal Can grew its stake in Acadia Healthcare by 2,456.1% during the third quarter. Bank of Montreal Can now owns 324,569 shares of the company’s stock worth $20,539,000 after buying an additional 311,871 shares in the last quarter. Finally, BNP Paribas Financial Markets increased its holdings in Acadia Healthcare by 1,601.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 281,220 shares of the company’s stock valued at $17,832,000 after buying an additional 264,690 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.